Company Email Format Management

Ablynx

Biotechnology Research Zwijnaarde Ghent, Be 125 employees

Employees: 125
Contacts: 3
Emails: 3

ablynx.com LinkedIn Crunchbase

Ablynx Overview

Headquarters: Zwijnaarde Ghent, Be
Phone Number: Available in AeroLeads
Website: ablynx.com
Industry: Biotechnology Research
Employees: 125
Funding: 230.0M
Company Email: Available in AeroLeads
NAICS: Research and Development in Biotechnology (except Nanobiotechnology)

Keywords

Discovery Research and Drug Development Nanobodies

About Ablynx

Ablynx, a Sanofi company, is engaged in the development of Nanobodies®, proprietary therapeutic proteins based on single-domain antibody fragments, which combine the advantages of conventional antibody drugs with some of the features of small-molecule drugs. Nanobodies have potential uses in the treatment of a range of serious and life-threatening human diseases. Ablynx advances a portfolio of Nanobody-based therapeutic programs in several major disease areas, including inflammation, haematology, immuno-oncology and oncology. The acquisition of Ablynx (June 2018) continues Sanofi’s commitment to breakthrough innovation, focused on technologies addressing multiple disease targets with single multi-specific molecules. Sanofi is committed to accelerating Ablynx’s Nanobody development programmes.

Ablynx Contact Details

People in AeroLeads: 4
With contact data: 3
Email contacts: 3; 75.0% coverage

Ablynx Org Chart

Sample employees and titles

Name	Title	Location	Contact
Katrien Verschueren	Biostatistician at Ablynx	Ghent Metropolitan Area, Belgium	Email
Tom Van Bogaert	Project Head - Distinguished Scientist		View
Ellen Foubert	Principal Scientist at Ablynx, a Sanofi	Ghent Metropolitan Area, Belgium	Email
Marie-Paule Bouche	Associate Director Pharmacology	Ghent Metropolitan Area, Belgium	Email